Comprehensive Financial Consultants Institutional, Inc. Bristol Myers Squibb CO Transaction History
Comprehensive Financial Consultants Institutional, Inc.
- $277 Million
- Q2 2025
A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 21,871 shares of BMY stock, worth $992,068. This represents 0.37% of its overall portfolio holdings.
Number of Shares
21,871
Previous 21,499
1.73%
Holding current value
$992,068
Previous $1.31 Million
22.81%
% of portfolio
0.37%
Previous 0.51%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,691Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.68 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.2 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.9 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.3 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.01 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...